Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Strongbridge Bio Ord (SBBP)

Strongbridge Bio Ord (SBBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 183,842
  • Shares Outstanding, K 67,589
  • Annual Sales, $ 30,730 K
  • Annual Income, $ -45,080 K
  • 60-Month Beta 1.60
  • Price/Sales 6.11
  • Price/Cash Flow N/A
  • Price/Book 3.35
Trade SBBP with:

Options Overview

Details
  • Implied Volatility 81.50%
  • Historical Volatility 49.14%
  • IV Percentile 9%
  • IV Rank 10.37%
  • IV High 351.03% on 08/28/20
  • IV Low 50.31% on 07/21/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 9
  • Volume Avg (30-Day) 41
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 3,425
  • Open Int (30-Day) 5,197

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.12
  • Number of Estimates 1
  • High Estimate -0.12
  • Low Estimate -0.12
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +62.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.59 +0.39%
on 07/15/21
3.19 -18.50%
on 07/06/21
-0.21 (-7.47%)
since 06/23/21
3-Month
2.24 +16.07%
on 05/19/21
3.19 -18.50%
on 07/06/21
unch (unch)
since 04/23/21
52-Week
1.87 +39.04%
on 10/29/20
4.40 -40.91%
on 08/06/20
-0.82 (-23.98%)
since 07/23/20

Most Recent Stories

More News
Somatostatin Receptor Type 4 (SSTR4) Drugs In Development, 2021 Research Report Featuring Eli Lilly and Co, GlyTech, Peptide Logic, Strongbridge Biopharma - ResearchAndMarkets.com

The "Somatostatin Receptor Type 4 (SSTR4) - Drugs In Development, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering.

LLY : 244.15 (+2.37%)
SBBP : 2.60 (-4.41%)
Axogen, Inc. Appoints John H. Johnson to Board of Directors

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that John H. Johnson has been appointed...

AXGN : 19.85 (+0.92%)
SBBP : 2.60 (-4.41%)
VSTM : 3.31 (-4.89%)
Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS(R) (dichlorphenamide) for the Treatment of Primary Periodic Paralysis in Muscle & Nerve

~ Study Confirms Long-Term Treatment with KEVEYIS is Safe and Effective for Chronic Use ~

SBBP : 2.60 (-4.41%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates SBBP, RFL, CLDB, MPB; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SBBP : 2.60 (-4.41%)
RFL : 51.63 (+2.20%)
CLDB : 26.61 (-0.50%)
MPB : 26.52 (-0.23%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds SLCT, DISCA, LORL, SBBP Shareholders About Its Ongoing Investigations

/PRNewswire/ --

DISCA : 28.47 (-0.04%)
DISCB : 54.55 (-0.37%)
DISCK : 26.83 (-0.30%)
SLCT : 15.10 (+0.33%)
LORL : 35.21 (-1.87%)
SBBP : 2.60 (-4.41%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, RIVE, ESXB, ICON, SBBP; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

RAVN : 58.68 (-0.53%)
RIVE : 12.72 (-0.16%)
ESXB : 10.55 (+1.15%)
ICON : 3.14 (+0.32%)
SBBP : 2.60 (-4.41%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of CLDR, KSU, SBBP, and DISCA Mergers

Rigrodsky Law, P.A. announces that it is investigating:

CLDR : 15.82 (+0.06%)
KSU : 271.40 (+0.62%)
SBBP : 2.60 (-4.41%)
DISCA : 28.47 (-0.04%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates MMAC, XEC, SBBP, SLCT; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

MMAC : 27.33 (unch)
XEC : 64.55 (+0.05%)
SBBP : 2.60 (-4.41%)
SLCT : 15.10 (+0.33%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds KNL, DTRC, SBBP, and CNST Shareholders About Its Ongoing Investigations

/PRNewswire/ --

KNL : 25.04 (+0.93%)
DTRC : 4.5600 (-5.59%)
SBBP : 2.60 (-4.41%)
CNST : 33.99 (+0.06%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates NCBS, SHSP, CLDB, SBBP; Shareholders are Encouraged to Contact the Firm

/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

NCBS : 69.61 (+0.13%)
SHSP : 16.84 (unch)
CLDB : 26.61 (-0.50%)
SBBP : 2.60 (-4.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Strongbridge Biopharma PLC is a biopharmaceutical company which develops, acquires and commercializes product candidates that target rare diseases. Its product candidate consists of COR-003, is a cortisol inhibitor, for the treatment of endogenous Cushing's syndrome, COR-004 and COR-005 to treat acromegaly,...

See More

Key Turning Points

3rd Resistance Point 2.83
2nd Resistance Point 2.79
1st Resistance Point 2.69
Last Price 2.60
1st Support Level 2.55
2nd Support Level 2.51
3rd Support Level 2.41

See More

52-Week High 4.40
Fibonacci 61.8% 3.43
Fibonacci 50% 3.13
Fibonacci 38.2% 2.84
Last Price 2.60
52-Week Low 1.87

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar